Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center … – Business Wire (press release)
Endpoints News |
Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center …
Business Wire (press release) SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced three license agreements to advance its program in multiple … Juno inks deals with Eli Lilly, the Hutch as it looks to leapfrog leaders on BCMA Juno inks three agreements to advance program in multiple myeloma; shares ahead 4% premarket |
